CNS Pharmaceuticals, Inc. (CNSP) Financials
CNSP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 2.3 million | 4.1 million |
2023-06-30 | 6.5 million | 4.0 million |
2023-03-31 | 7.4 million | 3.9 million |
2022-12-31 | 13.1 million | 4.9 million |
CNSP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.4 million | 194759 |
2023-06-30 | -3.4 million | 289670 |
2023-03-31 | -4.8 million | 290313 |
2022-12-31 | -2.3 million | 289719 |
CNSP Net Income
No data available :(
CNSP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 909547 | - | - |
2023-06-30 | 4.3 million | - | - |
2023-03-31 | 5.1 million | - | - |
2022-12-31 | 10.1 million | - | - |
CNSP Shares Outstanding
CNSP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1744 | 3.4 million | 1.1 million | - |
2023-06-30 | - | 2.8 million | 1.2 million | - |
2023-03-31 | - | 3.6 million | 1.4 million | - |
2022-12-31 | 1 | 3.3 million | 2.2 million | - |
CNSP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 899 |
2023-06-30 | - | 1003 |
2023-03-31 | - | 1279 |
2022-12-31 | - | 2381 |
CNSP
Price: $0.22
52 week price:
Earnings Per Share: -10.00 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 89600
Market Capitalization: 2.6 million